TrianglePUBLICATIONS · 36458426
A retrospective study of cladribine and low-dose cytarabine-based regimens for the treatment of chronic myelomonocytic leukemia and secondary acute myeloid leukemia.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Cancer
- Publication date
- 2023 Feb 15
- First author
- Bazinet A
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Bazinet A
- type
- Author
- name
- Darbaniyan F
- type
- Author
- name
- Kadia TM
- type
- Author
- name
- Venugopal S
- type
- Author
- name
- Kanagal-Shamanna R
- type
- Author
- name
- DiNardo CD
- type
- Author
- name
- Borthakur G
- type
- Author
- name
- Jabbour EJ
- type
- Author
- name
- Daver NG
- type
- Author
- name
- Pemmaraju N
- type
- Author
- name
- Konopleva MY
- type
- Author
- name
- Ravandi F
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Bazinet A
- type
- Author
- name
- Darbaniyan F
- type
- Author
- name
- Kadia TM
- type
- Author
- name
- Venugopal S
- type
- Author
- name
- Kanagal-Shamanna R
- type
- Author
- name
- DiNardo CD
- type
- Author
- name
- Borthakur G
- type
- Author
- name
- Jabbour EJ
- type
- Author
- name
- Daver NG
- type
- Author
- name
- Pemmaraju N
- type
- Author
- name
- Konopleva MY
- type
- Author
- name
- Ravandi F
- type
- Author
- bibliography ids
- nci-bib-3ae878984b46cb9f300a2d01
- book metadata
- content sha256
- a53a68e488fc3ea9fdd58cb41fe4ed7484d8f262adffa59a230b9b8fe11b1888
- document type
- citation
- dois
- 10.1002/cncr.34564
- electronic publication date
- display
- 2022 Dec 2
- precision
- day
- year
- 2022
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:36458426
- immutable id
- pubmed:36458426@a53a68e488fc3ea9fdd58cb41fe4ed7484d8f262adffa59a230b9b8fe11b1888
- journal
- abbreviation
- Cancer
- issn electronic
- 1097-0142
- issn print
- 0008-543X
- issue
- 4
- name
- Cancer
- nlm unique id
- 0374236
- pages
- 560-568
- volume
- 129
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 36458426
- provenance
- batch id
- d370e99271168e8a8a13
- provider
- NCBI PubMed ESummary
- record sha256
- d455b254a3016683cce4a04893f1734d786b157dbad3b21fe3b1c8ab777c9559
- response sha256
- f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
- retrieved at
- 2026-09-09T23:48:13.005737+00:00
- publication date
- display
- 2023 Feb 15
- precision
- day
- year
- 2023
- publication types
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- A retrospective study of cladribine and low-dose cytarabine-based regimens for the treatment of chronic myelomonocytic leukemia and secondary acute myeloid leukemia.
Preserved source evidence · Not medical advice